1-15 of 40
Racial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DR
OphthalmologyRacial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DR
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
Eye on Ocular HealthLogistical Considerations with Anti-VEGF Treatment in Wet AMD
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Eye on Ocular HealthTime to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
- advertisement
Outcomes for PDR Patients LTFU for at Least 1 Year
New Retina RadioOutcomes for PDR Patients LTFU for at Least 1 Year
Examining Therapeutic Timing in RVO-Related Macular Edema
Eye on Ocular HealthExamining Therapeutic Timing in RVO-Related Macular Edema
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
OphthalmologyReal-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Eye on Ocular HealthHow Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Suprachoroidal Steroids in Patients With a History of Glaucoma and Ocular Hypertension
OphthalmologySuprachoroidal Steroids in Patients With a History of Glaucoma and Ocular Hypertension
- advertisement
Tailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
Eye on Ocular HealthTailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
Mapping the Landscape: Diagnostic Tools in Corneal Health
EmpowerMapping the Landscape: Diagnostic Tools in Corneal Health





































































